ReShape Lifesciences Inc.
RSLS
$0.365
-$0.015-3.95%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 693.00K | 743.00K | 1.05M | 2.38M | 4.46M |
Total Receivables | 987.00K | 1.34M | 1.38M | 1.57M | 1.66M |
Inventory | 2.46M | 2.93M | 3.25M | 3.47M | 3.74M |
Prepaid Expenses | 334.00K | 161.00K | 244.00K | 303.00K | 198.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 114.00K | 156.00K | 162.00K | 180.00K | 239.00K |
Total Current Assets | 4.59M | 5.34M | 6.09M | 7.90M | 10.30M |
|
|||||
Total Current Assets | 4.59M | 5.34M | 6.09M | 7.90M | 10.30M |
Net Property, Plant & Equipment | 154.00K | 220.00K | 250.00K | 280.00K | 310.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 51.00K | 57.00K | 56.00K | 56.00K | 57.00K |
Total Assets | 4.79M | 5.62M | 6.39M | 8.23M | 10.66M |
|
|||||
Total Accounts Payable | 2.21M | 2.11M | 1.03M | 1.31M | 1.69M |
Total Accrued Expenses | 894.00K | 871.00K | 1.07M | 979.00K | 856.00K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 926.00K | 114.00K | 113.00K | 112.00K | 111.00K |
Total Finance Division Other Current Liabilities | 957.00K | 935.00K | 991.00K | 1.11M | 1.12M |
Total Other Current Liabilities | 957.00K | 935.00K | 991.00K | 1.11M | 1.12M |
Total Current Liabilities | 4.99M | 4.03M | 3.20M | 3.52M | 3.78M |
|
|||||
Total Current Liabilities | 4.99M | 4.03M | 3.20M | 3.52M | 3.78M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 41.00K | 77.00K | 103.00K | 127.00K | 151.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 20.00K | 26.00K | 54.00K | 51.00K | 72.00K |
Total Liabilities | 5.05M | 4.13M | 3.36M | 3.70M | 4.00M |
|
|||||
Common Stock & APIC | 642.56M | 642.52M | 642.49M | 642.40M | 642.33M |
Retained Earnings | -642.70M | -640.94M | -639.36M | -637.77M | -635.57M |
Treasury Stock & Other | -104.00K | -88.00K | -89.00K | -96.00K | -88.00K |
Total Common Equity | -253.00K | 1.49M | 3.04M | 4.53M | 6.66M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -253.00K | 1.49M | 3.04M | 4.53M | 6.66M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -253.00K | 1.49M | 3.04M | 4.53M | 6.66M |
|